Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic

Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic High-level description of when patients, practitioners and pharmacists are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic. 2021-01-06 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemic56(1) class exemptionControlled Drugs and Substances ActCDSApatientspractitionerspharmacistsprescriptionscontrolled substance Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemicHTML https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/policy-regulations/policy-documents/section-56-1-class-exemption-patients-pharmacists-practitioners-controlled-substances-covid-19-pandemic.html Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemicHTML https://www.canada.ca/fr/sante-canada/services/preoccupations-liees-sante/substances-controlees-precurseurs-chimiques/politique-reglementation/documents-politique/exemption-accordee-article-56-1-patients-pharmaciens-praticiens-prescription-substances-designees-pandemie-covid-19.html

High-level description of when patients, practitioners and pharmacists are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic.

Data and Resources

Similar records